Nicotine and cotinine are metabolized to pyridine-N-glucuronides in humans.
This suggests that the analogous metabolites of the carcinogenic nicotine-
related nitrosamines N'-nitrosonornicotine (NNN), 4-(methylnitrosamino)-1-(
3-pyridyl)-1-butanone (NNK), and 4-(methylnitrosamino)-1-(3-pyridyl)-1-buta
nol (NNAL) should also be formed in people exposed to these compounds via t
obacco products. We describe the synthesis of the appropriate pyridine-N-gl
ucuronides: pyridyl-N-beta -D-glucopyranuronosyl-N'-nitrosonornicotinium in
ner salt (NNN-N-Gluc, 8), 4-(methylnitrosamino)-1-(3-pyridyl-N-beta -D-gluc
opyranuronosyl)-1-butanonium inner salt (NNK-N-Gluc, 9), and 4-(methylnitro
samino)-1-(3-pyridyl-N-beta -D-glucopyranuronosyl)-1-butanolonium inner sal
t (NNAL-N-Gluc, 10). The starting material, methyl 2,3,4-tri-O-acetyl-1-bro
mo-1-deoxy-alpha -D-glucopyranuronate (1), is prepared in two steps from gl
ucuronolactone. Reactions of 1 with racemic NNN (2), NNK (3), or racemic NN
AL (4) are carried out with no solvent and the crude products are deprotect
ed by treatment with base, giving the desired N-glucuronides 8-10 in 5-7% o
verall yield after HPLC purification. The N-glucuronides were characterized
by H-1 NMR, including COSY and NOESY spectra, and by MS and MS/MS. NNN-N-G
luc exists as a 52:48 ratio of (E)- and (Z)-rotamers, which were partially
separated by HPLC. This ratio was surprisingly similar to the (E):(Z) ratio
for NNN itself suggesting hydrogen bonding of the (Z)-nitroso oxygen atom
to the 2"-hydroxyl group of the glucuronide moiety. Partial HPLC separation
s of the (E)- and (Z)-rotamers of NNK-N-Gluc and the (E)- and (Z)-rotamers
as well as the (R)- and (S)-diastereomers of NNAL-N-Gluc were also achieved
. The standards prepared in this study as well as the HPLC conditions devel
oped for their separation will be important for analysis of these compounds
in human urine.